S
VKTX icon

SignatureFD’s Viking Therapeutics VKTX Stock Holding History

SignatureFD’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.4K Sell
1,549
-49
-3% -$1.58K ﹤0.01% 1755
2026
Q1 		$52K Buy
1,598
+209
+15% +$6.72K ﹤0.01% 1696
2025
Q4 		$48.9K Sell
1,389
-16
-1% -$567 ﹤0.01% 1662
2025
Q3 		$36.9K Sell
1,405
-266
-16% -$7.94K ﹤0.01% 1808
2025
Q2 		$44.3K Sell
1,671
-1,159
-41% -$30.5K ﹤0.01% 1647
2025
Q1 		$68.3K Buy
2,830
+1,582
+127% +$50K ﹤0.01% 1409
2024
Q4 		$50.2K Sell
1,248
-103
-8% -$5.87K ﹤0.01% 1583
2024
Q3 		$85.5K Buy
1,351
+188
+16% +$11K ﹤0.01% 1296
2024
Q2 		$61.7K Sell
1,163
-289
-20% -$18.9K ﹤0.01% 1407
2024
Q1 		$119K Buy
1,452
+501
+53% +$22.3K ﹤0.01% 1096
2023
Q4 		$17.7K Sell
951
-510
-35% -$6.67K ﹤0.01% 1975
2023
Q3 		$16.2K Hold
1,461
– – ﹤0.01% 1962
2023
Q2 		$23.7K Hold
1,461
– – ﹤0.01% 1803
2023
Q1 		$24.3K Sell
1,461
-1,039
-42% -$10.7K ﹤0.01% 1760
2022
Q4 		$23.5K Hold
2,500
– – ﹤0.01% 1721
2022
Q3 		$7K Buy
+2,500
New +$8.19K ﹤0.01% 2284
2021
Q3 		– Sell
-191
Closed -$1K – 3224
2021
Q2 		$1K Hold
191
– – ﹤0.01% 2853
2021
Q1 		$1K Hold
191
– – ﹤0.01% 2695
2020
Q4 		$1K Buy
+191
New +$1.16K ﹤0.01% 2495
2020
Q2 		– Sell
-2
Closed – – 2679
2020
Q1 		$0 Hold
2
– – ﹤0.01% 2461
2019
Q4 		$0 Sell
2
-100
-98% -$729 ﹤0.01% 2288
2019
Q3 		$1K Hold
102
– – ﹤0.01% 2022
2019
Q2 		$1K Sell
102
-1
-1% -$9 ﹤0.01% 1960
2019
Q1 		$1K Sell
103
-497
-83% -$4.16K ﹤0.01% 1910
2018
Q4 		$5K Buy
600
+500
+500% +$5.98K ﹤0.01% 1549
2018
Q3 		$2K Hold
100
– – ﹤0.01% 1733
2018
Q2 		$1K Buy
+100
New +$665 ﹤0.01% 1858

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SignatureFD's VKTX Position: Q2 2026 in Review

SignatureFD reduced its Viking Therapeutics (VKTX) stake by 3.1% in Q2 2026, selling an estimated $1.58K and leaving 1,549 shares worth $60.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

SignatureFD first reported a position in VKTX in Q2 2018 and has held it in 27 quarters since. The position peaked at $119K in Q1 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • SignatureFD held 1,549 shares of Viking Therapeutics worth $60.4K as of Q2 2026.
  • SignatureFD sold 49 Viking Therapeutics shares in Q2 2026, an estimated $1.58K.
  • Viking Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1755 holding.
  • SignatureFD first reported a position in Viking Therapeutics in Q2 2018 and has held it in 27 quarters since.
  • SignatureFD's Viking Therapeutics position peaked at $119K in Q1 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.